The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|8|3|187-198

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.8, Iss.3, 2008-05, pp. : 187-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs

By  

Current Pharmaceutical Design, Vol. 16, Iss. 12, 2010-04 ,pp. : 1410-1416

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin Decreases Therapeutic Efficacy in Colon Cancer Cell Line HT29 Via the Activation of the PI3K/Akt Pathway

By  

Current Drug Discovery Technologies, Vol. 8, Iss. 2, 2011-06 ,pp. : 119-125

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of PI3K/Akt Pathway in Prostate Cancer - Potential Strategies for Developing Targeted Therapies

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 12, 2005-12 ,pp. : 1125-1132

Bentham Science Publishers

Access to resources Recommend Favorite

The PI3K/Akt Pathway: Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors

By  

Current Cancer Drug Targets, Vol. 8, Iss. 1, 2008-02 ,pp. : 7-18

Bentham Science Publishers

Access to resources Recommend Favorite

Salidroside attenuates myocardial ischemia–reperfusion injury via PI3K/Akt signaling pathway

By Xu Mao-Chun  

Journal of Asian Natural Products Research, Vol. 15, Iss. 3, 2013-03 ,pp. : 244-252

Taylor & Francis Ltd

Access to resources Recommend Favorite